341 related articles for article (PubMed ID: 33351783)
1. Cohesin mutations alter DNA damage repair and chromatin structure and create therapeutic vulnerabilities in MDS/AML.
Tothova Z; Valton AL; Gorelov RA; Vallurupalli M; Krill-Burger JM; Holmes A; Landers CC; Haydu JE; Malolepsza E; Hartigan C; Donahue M; Popova KD; Koochaki S; Venev SV; Rivera J; Chen E; Lage K; Schenone M; D'Andrea AD; Carr SA; Morgan EA; Dekker J; Ebert BL
JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351783
[TBL] [Abstract][Full Text] [Related]
2. Cohesin mutations in myeloid malignancies made simple.
Viny AD; Levine RL
Curr Opin Hematol; 2018 Mar; 25(2):61-66. PubMed ID: 29278534
[TBL] [Abstract][Full Text] [Related]
3. Splicing modulators impair DNA damage response and induce killing of cohesin-mutant MDS and AML.
Wheeler EC; Martin BJE; Doyle WC; Neaher S; Conway CA; Pitton CN; Gorelov RA; Donahue M; Jann JC; Abdel-Wahab O; Taylor J; Seiler M; Buonamici S; Pikman Y; Garcia JS; Belizaire R; Adelman K; Tothova Z
Sci Transl Med; 2024 Jan; 16(728):eade2774. PubMed ID: 38170787
[TBL] [Abstract][Full Text] [Related]
4. Genetic alterations of the cohesin complex genes in myeloid malignancies.
Thota S; Viny AD; Makishima H; Spitzer B; Radivoyevitch T; Przychodzen B; Sekeres MA; Levine RL; Maciejewski JP
Blood; 2014 Sep; 124(11):1790-8. PubMed ID: 25006131
[TBL] [Abstract][Full Text] [Related]
5. Cohesin Members Stag1 and Stag2 Display Distinct Roles in Chromatin Accessibility and Topological Control of HSC Self-Renewal and Differentiation.
Viny AD; Bowman RL; Liu Y; Lavallée VP; Eisman SE; Xiao W; Durham BH; Navitski A; Park J; Braunstein S; Alija B; Karzai A; Csete IS; Witkin M; Azizi E; Baslan T; Ott CJ; Pe'er D; Dekker J; Koche R; Levine RL
Cell Stem Cell; 2019 Nov; 25(5):682-696.e8. PubMed ID: 31495782
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutation of the cohesin complex subunit confers therapeutic vulnerabilities in cancer.
Liu Y; Xu H; Van der Jeught K; Li Y; Liu S; Zhang L; Fang Y; Zhang X; Radovich M; Schneider BP; He X; Huang C; Zhang C; Wan J; Ji G; Lu X
J Clin Invest; 2018 Jul; 128(7):2951-2965. PubMed ID: 29649003
[TBL] [Abstract][Full Text] [Related]
7. The role of mutations in the cohesin complex in acute myeloid leukemia.
Mazumdar C; Majeti R
Int J Hematol; 2017 Jan; 105(1):31-36. PubMed ID: 27796738
[TBL] [Abstract][Full Text] [Related]
8. A requirement for STAG2 in replication fork progression creates a targetable synthetic lethality in cohesin-mutant cancers.
Mondal G; Stevers M; Goode B; Ashworth A; Solomon DA
Nat Commun; 2019 Apr; 10(1):1686. PubMed ID: 30975996
[TBL] [Abstract][Full Text] [Related]
9. Glioblastoma cells containing mutations in the cohesin component STAG2 are sensitive to PARP inhibition.
Bailey ML; O'Neil NJ; van Pel DM; Solomon DA; Waldman T; Hieter P
Mol Cancer Ther; 2014 Mar; 13(3):724-32. PubMed ID: 24356817
[TBL] [Abstract][Full Text] [Related]
10. Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
Padella A; Ghelli Luserna Di Rorà A; Marconi G; Ghetti M; Martinelli G; Simonetti G
J Hematol Oncol; 2022 Jan; 15(1):10. PubMed ID: 35065680
[TBL] [Abstract][Full Text] [Related]
11. Redundant and specific roles of cohesin STAG subunits in chromatin looping and transcriptional control.
Casa V; Moronta Gines M; Gade Gusmao E; Slotman JA; Zirkel A; Josipovic N; Oole E; van IJcken WFJ; Houtsmuller AB; Papantonis A; Wendt KS
Genome Res; 2020 Apr; 30(4):515-527. PubMed ID: 32253279
[TBL] [Abstract][Full Text] [Related]
12. A cohesive look at leukemogenesis: The cohesin complex and other driving mutations in AML.
Heimbruch KE; Meyer AE; Agrawal P; Viny AD; Rao S
Neoplasia; 2021 Mar; 23(3):337-347. PubMed ID: 33621854
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the cohesin complex in acute myeloid leukemia: clinical and prognostic implications.
Thol F; Bollin R; Gehlhaar M; Walter C; Dugas M; Suchanek KJ; Kirchner A; Huang L; Chaturvedi A; Wichmann M; Wiehlmann L; Shahswar R; Damm F; Göhring G; Schlegelberger B; Schlenk R; Döhner K; Döhner H; Krauter J; Ganser A; Heuser M
Blood; 2014 Feb; 123(6):914-20. PubMed ID: 24335498
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of poly ADP-ribose polymerase (PARP) induce apoptosis of myeloid leukemic cells: potential for therapy of myeloid leukemia and myelodysplastic syndromes.
Gaymes TJ; Shall S; MacPherson LJ; Twine NA; Lea NC; Farzaneh F; Mufti GJ
Haematologica; 2009 May; 94(5):638-46. PubMed ID: 19407318
[TBL] [Abstract][Full Text] [Related]
15. Integrated genomic-metabolic classification of acute myeloid leukemia defines a subgroup with NPM1 and cohesin/DNA damage mutations.
Simonetti G; Mengucci C; Padella A; Fonzi E; Picone G; Delpino C; Nanni J; De Tommaso R; Franchini E; Papayannidis C; Marconi G; Pazzaglia M; Perricone M; Scarpi E; Fontana MC; Bruno S; Tebaldi M; Ferrari A; Bochicchio MT; Ghelli Luserna Di Rorà A; Ghetti M; Napolitano R; Astolfi A; Baldazzi C; Guadagnuolo V; Ottaviani E; Iacobucci I; Cavo M; Castellani G; Haferlach T; Remondini D; Capozzi F; Martinelli G
Leukemia; 2021 Oct; 35(10):2813-2826. PubMed ID: 34193978
[TBL] [Abstract][Full Text] [Related]
16. Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.
Kon A; Shih LY; Minamino M; Sanada M; Shiraishi Y; Nagata Y; Yoshida K; Okuno Y; Bando M; Nakato R; Ishikawa S; Sato-Otsubo A; Nagae G; Nishimoto A; Haferlach C; Nowak D; Sato Y; Alpermann T; Nagasaki M; Shimamura T; Tanaka H; Chiba K; Yamamoto R; Yamaguchi T; Otsu M; Obara N; Sakata-Yanagimoto M; Nakamaki T; Ishiyama K; Nolte F; Hofmann WK; Miyawaki S; Chiba S; Mori H; Nakauchi H; Koeffler HP; Aburatani H; Haferlach T; Shirahige K; Miyano S; Ogawa S
Nat Genet; 2013 Oct; 45(10):1232-7. PubMed ID: 23955599
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the Cytotoxic Effects of PARP Inhibitors with DNA Demethylating Agents - A Potential Therapy for Cancer.
Muvarak NE; Chowdhury K; Xia L; Robert C; Choi EY; Cai Y; Bellani M; Zou Y; Singh ZN; Duong VH; Rutherford T; Nagaria P; Bentzen SM; Seidman MM; Baer MR; Lapidus RG; Baylin SB; Rassool FV
Cancer Cell; 2016 Oct; 30(4):637-650. PubMed ID: 27728808
[TBL] [Abstract][Full Text] [Related]
18. [Molecular pathogenesis of myelodysplastic syndromes with concurrent mutations in cohesin STAG2 and transcription factor RUNX1].
Ochi Y
Rinsho Ketsueki; 2021; 62(5):352-359. PubMed ID: 34108313
[TBL] [Abstract][Full Text] [Related]
19. Cohesin mutations in myeloid malignancies.
Jann JC; Tothova Z
Blood; 2021 Aug; 138(8):649-661. PubMed ID: 34157074
[TBL] [Abstract][Full Text] [Related]
20. Whole Exome Sequencing Identifies Cohesin Component STAG1 Mutation in de novo Acute Myeloid Leukemia (FAB M2): A Pilot Study with Cytogenetics, Clinical and Prognostic Implications.
Sakthivel KM; Geetha N; Raj TVA; Chandran RK; Krishna KMNJ; Sreedharan H
J Environ Pathol Toxicol Oncol; 2021; 40(1):51-64. PubMed ID: 33639073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
